Review



snuh-2004-gc tissue microarray  (SuperBioChips)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SuperBioChips snuh-2004-gc tissue microarray
    Patients’ demographic data of SNUH-2004-GC for <t> tissue microarrays. </t>
    Snuh 2004 Gc Tissue Microarray, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snuh-2004-gc+tissue+microarray/snuh+2004+gc+tissue+microarray/pmc03884694-198-251-248
    Average 90 stars, based on 1 article reviews
    snuh-2004-gc tissue microarray - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer"

    Article Title: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer

    Journal: Annals of surgical oncology

    doi: 10.1245/s10434-011-2125-1

    Patients’ demographic data of SNUH-2004-GC for tissue microarrays.
    Figure Legend Snippet: Patients’ demographic data of SNUH-2004-GC for tissue microarrays.

    Techniques Used:

    Related Articles

    Staining:

    Article Title: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer
    Article Snippet: The staining patterns of MUC13, CDH17, OLFM4, KRT20, LGALS4, MUC5AC and REG4 in the SNUH-2004-GC TMA are shown in . fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1 caption a7 Protein expression using immunohistochemical staining (100x). membranous type MUC13; MUC13m (1a), cytoplasmic type MUC13; MUC13c (1b), CDH17 (1c), LGALS4 (1d), REG4 (1e), OLFM4 (1f), MUC5AC (1g) and KRT20 (1h). table ft1 table-wrap mode="anchored" t5 caption a7 SNUH-2004-GC n=450 Age (yr) 57.5±12.7 Male to Female ratio 2.7 :1 Location Upper 83 (18.4%) Mid 126 (28.0%) Lower 220 (48.9%) Entire 20 (4.4%) Remnant 1 (0.2%) WHO Papillary 2 (0.4%) Well differentiated 30 (6.7%) Moderately differentiated 155 (34.4%) Poorly differentiated 159 (35.3%) Mucinous 14 (3.1%) Signet Ring cell 82 (18.2%) Undetermined 8 (1.8%) Lauren Intestinal 185 (41.1%) Diffuse 185 (41.1%) Mixed 77 (17.1%) Undetermined 3 (0.7%) Lymphatic invasion 262 (58.2%) Venous invasion 77 (17.1%) Perineural invasion 217 (48.2%) Size (cm) 5.6±3.1 metastatic LN 5.6±8.7 Retrieved LN 31.4±12.9 Radicality R0 403 (89.6%) R1/R2 47 (10.4%) T stage T1 128 (28.4%) T2 71 (15.8%) T3 155 (34.4%) T4 96 (21.3%) N stage N0 192 (42.7%) N1 63 (14.0%) N2 60 (13.3%) N3 135 (30.0%) M stage M0 397 (88.2%) M1 53 (11.8%) TNM stage Stage I 157 (34.9%) Stage II 102 (22.7%) Stage III 138 (30.7%) Stage IV 53 (11.8%) F/U month (mo) 49 (0-64) Open in a separate window SNUH-2004-GC indicates the collection of 450 gastric adenocarcinomas resected at Seoul National University Hospital in 2004 (SuperBioChips) used for tissue microarrays.

    Expressing:

    Article Title: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer
    Article Snippet: The staining patterns of MUC13, CDH17, OLFM4, KRT20, LGALS4, MUC5AC and REG4 in the SNUH-2004-GC TMA are shown in . fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1 caption a7 Protein expression using immunohistochemical staining (100x). membranous type MUC13; MUC13m (1a), cytoplasmic type MUC13; MUC13c (1b), CDH17 (1c), LGALS4 (1d), REG4 (1e), OLFM4 (1f), MUC5AC (1g) and KRT20 (1h). table ft1 table-wrap mode="anchored" t5 caption a7 SNUH-2004-GC n=450 Age (yr) 57.5±12.7 Male to Female ratio 2.7 :1 Location Upper 83 (18.4%) Mid 126 (28.0%) Lower 220 (48.9%) Entire 20 (4.4%) Remnant 1 (0.2%) WHO Papillary 2 (0.4%) Well differentiated 30 (6.7%) Moderately differentiated 155 (34.4%) Poorly differentiated 159 (35.3%) Mucinous 14 (3.1%) Signet Ring cell 82 (18.2%) Undetermined 8 (1.8%) Lauren Intestinal 185 (41.1%) Diffuse 185 (41.1%) Mixed 77 (17.1%) Undetermined 3 (0.7%) Lymphatic invasion 262 (58.2%) Venous invasion 77 (17.1%) Perineural invasion 217 (48.2%) Size (cm) 5.6±3.1 metastatic LN 5.6±8.7 Retrieved LN 31.4±12.9 Radicality R0 403 (89.6%) R1/R2 47 (10.4%) T stage T1 128 (28.4%) T2 71 (15.8%) T3 155 (34.4%) T4 96 (21.3%) N stage N0 192 (42.7%) N1 63 (14.0%) N2 60 (13.3%) N3 135 (30.0%) M stage M0 397 (88.2%) M1 53 (11.8%) TNM stage Stage I 157 (34.9%) Stage II 102 (22.7%) Stage III 138 (30.7%) Stage IV 53 (11.8%) F/U month (mo) 49 (0-64) Open in a separate window SNUH-2004-GC indicates the collection of 450 gastric adenocarcinomas resected at Seoul National University Hospital in 2004 (SuperBioChips) used for tissue microarrays.

    Immunohistochemical staining:

    Article Title: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer
    Article Snippet: The staining patterns of MUC13, CDH17, OLFM4, KRT20, LGALS4, MUC5AC and REG4 in the SNUH-2004-GC TMA are shown in . fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1 caption a7 Protein expression using immunohistochemical staining (100x). membranous type MUC13; MUC13m (1a), cytoplasmic type MUC13; MUC13c (1b), CDH17 (1c), LGALS4 (1d), REG4 (1e), OLFM4 (1f), MUC5AC (1g) and KRT20 (1h). table ft1 table-wrap mode="anchored" t5 caption a7 SNUH-2004-GC n=450 Age (yr) 57.5±12.7 Male to Female ratio 2.7 :1 Location Upper 83 (18.4%) Mid 126 (28.0%) Lower 220 (48.9%) Entire 20 (4.4%) Remnant 1 (0.2%) WHO Papillary 2 (0.4%) Well differentiated 30 (6.7%) Moderately differentiated 155 (34.4%) Poorly differentiated 159 (35.3%) Mucinous 14 (3.1%) Signet Ring cell 82 (18.2%) Undetermined 8 (1.8%) Lauren Intestinal 185 (41.1%) Diffuse 185 (41.1%) Mixed 77 (17.1%) Undetermined 3 (0.7%) Lymphatic invasion 262 (58.2%) Venous invasion 77 (17.1%) Perineural invasion 217 (48.2%) Size (cm) 5.6±3.1 metastatic LN 5.6±8.7 Retrieved LN 31.4±12.9 Radicality R0 403 (89.6%) R1/R2 47 (10.4%) T stage T1 128 (28.4%) T2 71 (15.8%) T3 155 (34.4%) T4 96 (21.3%) N stage N0 192 (42.7%) N1 63 (14.0%) N2 60 (13.3%) N3 135 (30.0%) M stage M0 397 (88.2%) M1 53 (11.8%) TNM stage Stage I 157 (34.9%) Stage II 102 (22.7%) Stage III 138 (30.7%) Stage IV 53 (11.8%) F/U month (mo) 49 (0-64) Open in a separate window SNUH-2004-GC indicates the collection of 450 gastric adenocarcinomas resected at Seoul National University Hospital in 2004 (SuperBioChips) used for tissue microarrays.



    Similar Products

    snuh-2004-gc tissue microarray  (SuperBioChips)
    90
    SuperBioChips snuh-2004-gc tissue microarray
    Patients’ demographic data of SNUH-2004-GC for <t> tissue microarrays. </t>
    Snuh 2004 Gc Tissue Microarray, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snuh-2004-gc+tissue+microarray/snuh+2004+gc+tissue+microarray/pmc03884694-198-251-248
    Average 90 stars, based on 1 article reviews
    snuh-2004-gc tissue microarray - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Patients’ demographic data of SNUH-2004-GC for tissue microarrays.

    Journal: Annals of surgical oncology

    Article Title: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer

    doi: 10.1245/s10434-011-2125-1

    Figure Lengend Snippet: Patients’ demographic data of SNUH-2004-GC for tissue microarrays.

    Article Snippet: The staining patterns of MUC13, CDH17, OLFM4, KRT20, LGALS4, MUC5AC and REG4 in the SNUH-2004-GC TMA are shown in . fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1 caption a7 Protein expression using immunohistochemical staining (100x). membranous type MUC13; MUC13m (1a), cytoplasmic type MUC13; MUC13c (1b), CDH17 (1c), LGALS4 (1d), REG4 (1e), OLFM4 (1f), MUC5AC (1g) and KRT20 (1h). table ft1 table-wrap mode="anchored" t5 caption a7 SNUH-2004-GC n=450 Age (yr) 57.5±12.7 Male to Female ratio 2.7 :1 Location Upper 83 (18.4%) Mid 126 (28.0%) Lower 220 (48.9%) Entire 20 (4.4%) Remnant 1 (0.2%) WHO Papillary 2 (0.4%) Well differentiated 30 (6.7%) Moderately differentiated 155 (34.4%) Poorly differentiated 159 (35.3%) Mucinous 14 (3.1%) Signet Ring cell 82 (18.2%) Undetermined 8 (1.8%) Lauren Intestinal 185 (41.1%) Diffuse 185 (41.1%) Mixed 77 (17.1%) Undetermined 3 (0.7%) Lymphatic invasion 262 (58.2%) Venous invasion 77 (17.1%) Perineural invasion 217 (48.2%) Size (cm) 5.6±3.1 metastatic LN 5.6±8.7 Retrieved LN 31.4±12.9 Radicality R0 403 (89.6%) R1/R2 47 (10.4%) T stage T1 128 (28.4%) T2 71 (15.8%) T3 155 (34.4%) T4 96 (21.3%) N stage N0 192 (42.7%) N1 63 (14.0%) N2 60 (13.3%) N3 135 (30.0%) M stage M0 397 (88.2%) M1 53 (11.8%) TNM stage Stage I 157 (34.9%) Stage II 102 (22.7%) Stage III 138 (30.7%) Stage IV 53 (11.8%) F/U month (mo) 49 (0-64) Open in a separate window SNUH-2004-GC indicates the collection of 450 gastric adenocarcinomas resected at Seoul National University Hospital in 2004 (SuperBioChips) used for tissue microarrays.

    Techniques: